Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enemas are hypertonic saline solutions used as a laxative for bowel cleansing.
## Primary Indications
* Bowel preparation prior to colonoscopy or surgery.
* Relief of occasional constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) bottle administered as a single dose, or sometimes two doses (one 4.5 oz bottle followed by another 4.5 oz bottle 10-12 hours later), depending on the specific protocol. Follow the instructions on the product label carefully.
* **Constipation:** One 2.25 oz (66 mL) bottle administered as a single dose.
## Pediatric Dosing
* **Ages 0-2 years:** Not recommended.
* **Ages 2-5 years:** One-half of the 2.25 oz (66 mL) bottle (approximately 1.125 oz or 33 mL). Use with caution and under medical supervision.
* **Ages 6-11 years:** One 2.25 oz (66 mL) bottle.
* **Ages 12 years and older:** Adult dosing.
## Dose Adjustments
No specific dose adjustments are routinely required for hepatic or renal impairment, but caution is warranted in patients with pre-existing electrolyte imbalances or impaired renal function due to the risk of hypernatremia and hyperphosphatemia.
## Contraindications
* Congestive heart failure.
* Anuria, oliguria, or renal insufficiency.
* Congenital or acquired megacolon.
* Intestinal obstruction or perforation.
* Marked abdominal distension.
* Children less than 2 years of age.
* Patients with inflammatory bowel disease (risk of electrolyte disturbances).
* Patients with risk factors for dehydration or electrolyte abnormalities (e.g., elderly, those on diuretics or ACE inhibitors).
## Adverse Effects
* Common: Abdominal cramping, nausea, vomiting, bloating, rectal irritation.
* Serious: Hypernatremia, hyperphosphatemia, hypocalcemia, hypokalemia, dehydration, renal failure, cardiac arrhythmias, seizures. These are more likely in patients with contraindications or with overuse.
## Key Drug Interactions
* **Diuretics, ACE Inhibitors, ARBs, NSAIDs:** Increased risk of hypernatremia, hyperphosphatemia, and renal impairment due to potential for fluid and electrolyte depletion.
* **Drugs affecting bowel motility:** May alter the effectiveness of sodium phosphate enemas.
## Monitoring
* Electrolytes (sodium, phosphate, calcium, potassium) and renal function, especially in at-risk patients or with repeated use.
* Signs of dehydration or fluid/electrolyte imbalance (e.g., dizziness, confusion, decreased urine output, excessive thirst).
## Clinical Pearls
* Instruct patients to drink plenty of clear fluids before and after use to prevent dehydration and electrolyte imbalances.
* Do not use if bowel movements have not occurred for more than 3 days, or if experiencing nausea, vomiting, or abdominal pain, as these may be signs of a more serious condition.
* Do not administer more than one enema in a 24-hour period.
* The use of sodium phosphate enemas has been associated with cases of severe electrolyte disturbances, particularly acute phosphate nephropathy, renal failure, and even fatalities, especially in elderly patients or those with pre-existing renal disease. Due to these risks, other bowel preparation agents may be preferred when possible.
***
*Disclaimer: This information is intended for healthcare professionals and does not replace the need to consult the official prescribing information or other relevant clinical resources. Dosing and recommendations may vary based on individual patient factors and local protocols. Always verify current drug information before making clinical decisions.*
